Basic information Safety Supplier Related

2,4-DICHLORO-5-(CHLOROMETHYL)-PYRIDINE

Basic information Safety Supplier Related

2,4-DICHLORO-5-(CHLOROMETHYL)-PYRIDINE Basic information

Product Name:
2,4-DICHLORO-5-(CHLOROMETHYL)-PYRIDINE
Synonyms:
  • 2,4-DICHLORO-5-(CHLOROMETHYL)-PYRIDINE
  • Pyridine, 2,4-dichloro-5-(chloromethyl)- (9CI)
  • Pyridine, 2,4-dichloro-5-(chloromethyl)-
CAS:
73998-96-6
MF:
C6H4Cl3N
MW:
196.46
Product Categories:
  • HALOMETYL
Mol File:
73998-96-6.mol
More
Less

2,4-DICHLORO-5-(CHLOROMETHYL)-PYRIDINE Chemical Properties

Boiling point:
274℃
Density 
1.463
Flash point:
146℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-0.28±0.10(Predicted)
Appearance
White to yellow Solid
More
Less

2,4-DICHLORO-5-(CHLOROMETHYL)-PYRIDINE Usage And Synthesis

Synthesis

73998-95-5

73998-96-6

General procedure for the synthesis of 2,4-dichloro-5-(chloromethyl)-pyridine from (4,6-dichloropyridin-3-yl)methanol: To a stirred solution of (4,6-dichloropyridin-3-yl)methanol (2.5 g, 14 mmol) in dichloromethane (20 mL) was slowly added thionyl chloride (1.2 mL, 14 mmol) at room temperature. The reaction mixture was stirred for 15 min, then cooled to 0 °C and washed with saturated aqueous sodium bicarbonate. The organic phase was dried with anhydrous magnesium sulfate, concentrated under reduced pressure, and purified by rapid chromatography on silica gel (eluent: dichloromethane) to afford 2,4-dichloro-5-(chloromethyl)-pyridine (1.3 g, 47% yield).

References

[1] Patent: US2005/192310, 2005, A1. Location in patent: Page/Page column 32
[2] Patent: US4191831, 1980, A

2,4-DICHLORO-5-(CHLOROMETHYL)-PYRIDINESupplier

JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com
Jinan Trio PharmaTech Co., Ltd.
Tel
0531-88811783
Email
sales@trio-pharmatech.com
Shanghai Hekang Biotechnology Co., Ltd.
Tel
18939837085
Email
youchemicals@gmail.com
Cochemical Ltd.
Tel
029-86115547 17791676824
Email
sales@cochemical.com
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com